Jamjoom Pharma unveils SAR 154m interim dividends for H1-26

JAMJOOM PHARMA
4015 -0.34% 146.60 -0.50 2P
7204.B 0.00% 0.00 0.00

Riyadh - Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has approved the distribution of SAR 154 million in interim cash dividends to shareholders for the first half (H1) of 2026.

The total payout is based on 70 million outstanding shares, according to a bourse disclosure.

The dividend is set at SAR 2.20 per share, representing 22% of the stock's nominal value.

Eligibility for the distribution is scheduled for 30 July 2026 for shareholders registered with the Securities Depository Center at the end of the second trading day following the eligibility date.

The company confirmed that the payment process will commence on 13 August 2026.

For non-resident investors, the dividend distributions will be subject to a 5% withholding tax in accordance with Saudi tax regulations.

Jamjoom Pharma urged shareholders to ensure their bank account details are correctly linked to their investment portfolios to facilitate the electronic transfer of funds. The board's decision to approve the payout was finalized on 21 July 2026.

The group recorded net profits totaling SAR 137.63 million for the second quarter (Q2) of 2026, an annual growth of 4.25% from SAR 132.02 million.

Source: Mubasher Source: {{details.article.source}}